Symposium Speaker - Dr Paul Downie

Dr Downie is a Consultant Lipidologist/Chemical Pathologist at the University Hospitals of Bristol NHS Foundation Trust. This is a busy tertiary centre which looks after patients with common lipid disorders as well as rarer lipid conditions including Homozygous FH. Bristol has an active research programme and Dr Downie is currently a principal investigator and sub-investigator on several large several large cardiovascular trials. Dr Downie’s particular areas of interest include optimisation of lipids in secondary prevention, lipoprotein(a), apheresis and in particular hypertriglyceridemia, having established the only NGS assay in the UK (now included in the National Genomics Test Directory) for the investigation of genetic causes of severe hypertriglyceridemia.

In addition he was until recently a specialist CVD advisor for the West of England Health Innovation Network and is also regional Training Programme Director for Chemical Pathology in the South West.

Formerly a GP partner he also understands the challenges faced by colleagues in general practice and is passionate about the critical need to bring a pragmatic approach to patient care. He enjoys working with primary care colleagues to help optimise community CV risk management.